Transpek Industry Intrinsic Value
Valuation
Blended fair value using DCF and peer comparison methods.
Transpek Industry Intrinsic Value Analysis
The latest available EOD closing price for Transpek Industry (TRANSPEK) is ₹1,233 per share. Understock's estimated intrinsic value is ₹3,890 per share. This estimate is 215.6% above that price; the page's comparison band labels the shares undervalued.
The displayed estimate uses the available peer-based value of ₹3,890; a DCF estimate is not currently available. Peer comparison uses 8 matched industry companies and contributing P/E, P/B multiples.
For context, available company data reports P/E of 17.7×. These metrics describe the business and are not separate intrinsic-value estimates.
How Understock Calculates Intrinsic Value
Understock follows the company's stored valuation classification. Where DCF applies, the model discounts projected or normalized cash flows and terminal value using stored assumptions. Peer valuation compares available company multiples with medians from matched industry or sector companies, with a curated peer-group fallback where database matches are unavailable; the contributing multiples and their weights depend on sector rules and available data. For this page, the available displayed estimate comes from peer valuation. DCF and peer estimates can differ because they use different assumptions, financial metrics, and market reference points.
Review this company's DCF valuation · Learn how DCF works · Use the DCF calculator · See Transpek Industry peer valuation · What intrinsic value means
The intrinsic value shown is an algorithmic estimate based on publicly available financial data — including DCF analysis, peer comparison, and historical financials. It is not a research report, investment advice, or a recommendation to buy, sell, or hold any security. Stock valuations involve uncertainty and may differ significantly from market prices. Please consult a SEBI-registered investment adviser before making any investment decision.
Transpek Industry Peer Comparison
How this company stacks up against sector peers on valuation and quality metrics.
Chemicals · 8 peers · sector medians shown
| Company | Mkt Cap | P/E | P/B | EV/EBITDA | ROE | Net Margin | Rev CAGR 3y |
|---|---|---|---|---|---|---|---|
Transpek Industry TRANSPEK · you | ₹689 Cr | 17.7× | 0.9× | — | 4.9% | 0.1% | — |
| Sector median | — | 48.4× | 3.4× | 26.9× | 9.1% | 3.0% | 5.9% |
| Dhanuka Agritech Limited DHANUKA | ₹4,646 Cr | 15.9× | 2.7× | 10.5× | 17.1% | 14.2% | 5.9% |
| Laxmi Organic Industries Limited LXCHEM | ₹4,518 Cr | 56.9× | 2.3× | 26.9× | 4.0% | 2.8% | 0.6% |
| Neogen Chemicals Limited NEOGEN | ₹4,442 Cr | 196.3× | 6.9× | 41.8× | 3.5% | 3.3% | 7.9% |
| GHCL Limited GHCL | ₹4,194 Cr | 8.7× | 1.1× | 4.5× | 13.3% | 15.4% | -12.3% |
| Rallis India Limited RALLIS | ₹4,138 Cr | 19.4× | 2.1× | — | 11.1% | 0.1% | — |
| Vishnu Chemicals Limited VISHNU | ₹4,088 Cr | 39.8× | 6.1× | — | 15.3% | 0.1% | — |
| Foseco India Limited FOSECOIND | ₹4,072 Cr | 57.7× | 4.0× | 38.6× | 7.0% | 11.2% | 16.5% |
| Tatva Chintan Pharma Chem Limited TATVA | ₹4,021 Cr | 90.6× | 5.6× | — | 6.2% | 0.1% | — |
Transpek trades at a discount to sector peers on P/E (17.7× vs median 48.4×). This may signal undervaluation — or reflect lower expected growth or higher perceived risk versus the peer group.
Business quality
Valuation
Returns
Growth
Efficiency
Liquidity & Solvency
Financial health
Piotroski F-Score, Altman Z-Score, and key solvency ratios.
Full financial data
Charts and annual statements for income, balance sheet and cash flow.
Income trend
Revenue, profit and margin trends over time.
Cash flow
Where cash comes from and where it goes.
Balance sheet
Assets show what the company owns. Liabilities show what it owes. Equity is what's left for shareholders.